FierceBiotech ٢٥ نوفمبر ٢٠٢٥ <a href="https://www.fiercebiotech.com/biotech/bayers-asundexian-cuts-stroke-risk-phase-3-reviving-hopes-fxia-class" hreflang="en">Bayer's asundexian cuts stroke risk in phase 3, reviving hopes for FXIa class</a> #Bayer asundexian #reviving hopes